Editorial: Don’t rush to rehabilitate Hwang
By Editorial,
Nature
| 01. 21. 2014
An article published on Nature’s website last week has created quite a buzz in South Korea. It details efforts by former Seoul National University cloning specialist Woo Suk Hwang to rehabilitate his scientific career after he was found in 2006 to have been involved in fraud. Some in South Korea are taking the article as a sign that Hwang is now producing great science and is once again lauded by the scientific community. Stock prices of companies with connections to Hwang’s work have apparently jumped. It is as if many of the people talking and writing about the article have not read it. They and others can do so now if they wish: it appears as a News Feature on page 468.
As readers will see, the article is not a show of support for Hwang’s research. Nor is it an attack. It is the story of a rare event: a scientist attempting with some success to dig himself out from the depths of ignominy. It is a journalistic exercise, not a scientific endorsement. And it was commissioned to...
Related Articles
By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026
This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the...
By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026
This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...